Zhejiang Jiuzhou Pharmaceutical Co., Ltd. (tom qab no hu ua "Company") tau txaisDaim Ntawv Pom Zoo Pom Zoo rau Kev Siv Tshuaj Siv Tshuaj Siv Tshuaj (API) Daim Ntawv Thov Kev Lag Luamrau Vilazodone Hydrobromide, muab los ntawm National Medical Products Administration (tom qab no hu ua "NMPA").
Vilazodone Hydrobromide feem ntau yog siv rau kev kho mob ntawm kev nyuaj siab loj (MDD) hauv cov neeg laus. Lub Tuam Txhab xa daim ntawv thov kev lag luam rau cov khoom siv tshuaj nquag (API) mus rau Lub Chaw rau Kev Ntsuas Tshuaj (tom qab no hu ua "CDE") ntawm National Medical Products Administration thaum Lub Kaum Hli 2023, thiab nyuam qhuav tau txaisDaim Ntawv Ceeb Toom Pom Zoo rau Kev Siv Tshuaj API Kev Lag Luammuab los ntawm National Medical Products Administration. Cov xwm txheej ntawm API no ntawm CDE's Registration Information Platform for Excipients, APIs thiab Packaging Materials yog qhia tias "A". Txog tam sim no, Lub Tuam Txhab tau sau tag nrho R & D peev ntawm kwv yees li RMB 4.29 lab hauv Vilazodone Hydrobromide. Tam sim no, cov tuam txhab tseem ceeb hauv tsev ntawm Vilazodone Hydrobromide API suav nrog Jiangsu Nhwa Pharmaceutical Co., Ltd. thiab Jilin Huikang Pharmaceutical Co., Ltd. Raws li cov ntaub ntawv pej xeem, kev muag ntim ntawm Vilazodone Hydrobromide Tablets hauv lub davhlau ya nyob twg ntawm Tuam Tshoj cov chaw kho mob pej xeem tau tshaj RMB 150 lab hauv 202. xyoo-ntawm-xyoo loj hlob ntawm 6.52%.
